Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
78 participants
INTERVENTIONAL
2020-10-19
2021-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Inhibitory Control Training in Eating Behaviors
NCT03599115
Weight Loss Through Mayo Clinic Diet
NCT06862375
Food, Activity and Behavior Study
NCT04577547
Effects of the GOLO Weight Management Program With and Without Release Supplement on Weight and Metabolic Parameters in Subjects With Obesity
NCT03842501
Testing Intervention Strategies for Addressing Obesity and Binge Eating
NCT04771455
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High Dose
Participants will perform the food-specific computerized go/no-go training four times per week for 4 weeks.
food-specific go/no-go computerized training
Participants will perform the computerized food specific go/no-go training a designated number of times over a four week duration (frequency varies by group). Each training session will last approximately 10 minutes and occur on different days of the week.
Low Dose
Participants will perform the food-specific computerized go/no-go training one time per week for 4 weeks.
food-specific go/no-go computerized training
Participants will perform the computerized food specific go/no-go training a designated number of times over a four week duration (frequency varies by group). Each training session will last approximately 10 minutes and occur on different days of the week.
Active Control
Participants will perform the generalized, nonfood-specific computerized go/no-go training one time per week for 4 weeks.
nonfood-specific go/no-go computerized training
Participants will perform the computerized general go/no-go training 1 time per week over a four week duration. Each training session will last approximately 10 minutes and occur on different days of the week.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
food-specific go/no-go computerized training
Participants will perform the computerized food specific go/no-go training a designated number of times over a four week duration (frequency varies by group). Each training session will last approximately 10 minutes and occur on different days of the week.
nonfood-specific go/no-go computerized training
Participants will perform the computerized general go/no-go training 1 time per week over a four week duration. Each training session will last approximately 10 minutes and occur on different days of the week.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18
* Consume some of the determined "no-go" snack foods at least three times per week (assessed using a food frequency questionnaire)
* A desire to lose weight
Exclusion Criteria
* Medical condition directly affecting weight
* Current use of weight loss medication
* Actively enrolled in a formal weight loss program currently or within the past 6 months (e.g., Weight Watchers)
* History of bariatric surgery
* Currently pregnant
* Current smoker
* Smoking cessation within the past year
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Minnesota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lara LaCaille, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Minnesota
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Minnesota Duluth
Duluth, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
00010522
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.